20 LATEST RESOURCES (560 INDEXED)
×
Factors Associated with Frequent Buprenorphine / Naloxone Initiation in a National Survey of Canadian Emergency Physicians · February 2024
Articles
PLOS ONE
×
Implementation of an Education Session on Buprenorphine Induction in the Emergency Department, a Resident-Led Initiative · January 2024
Articles
Harm Reduction Journal
×
Prevalence of Current Restless Legs Syndrome Symptoms among Patients Treated with Buprenorphine/Naloxone for Opioid Use Disorder · October 2023
Articles
Nature and Science of Sleep
×
Buprenorphine Plasma and Cerebrospinal Fluid Concentrations in Osteoarthritis Patients during Low-Dose Transdermal Patch Dosing · October 2023
Articles
European Journal of Clinical Pharmacology
×
Differences in Medicaid Expansion Effects on Buprenorphine Treatment Utilization by County Rurality and Income: A Pharmacy Data Claims Analysis from 2009–2018 · October 2023
Articles
Drug and Alcohol Dependence Reports
×
Buprenorphine Dose and Time to Discontinuation among Patients with Opioid Use Disorder in the Era of Fentanyl · September 2023
Articles
JAMA Network Open
×
Emergency-Department Initiated Buprenorphine: Impact on Quality of Life · September 2023
Articles
Drug and Alcohol Dependence Reports
×
Economic Evaluation of Extended-Release Buprenorphine for Persons with Opioid Use Disorder · September 2023
Articles
JAMA Network Open
×
The Experience of Buprenorphine Implant in Patients with Opioid Use Disorder: A Series of Narrative Interviews · August 2023
Articles
Frontiers in Psychiatry
×
Buprenorphine Deregulation as an Opioid Crisis Policy Response – A Comparative Analysis between France and the United States · August 2023
Articles
International Journal of Drug Policy
×
Implementing Buprenorphine Prolonged-Release Injection Using a Health at the Margins Approach for Transactional Sex-Workers · July 2023
Articles
Frontiers in Psychiatry
×
Successful Management of Kratom Use Disorder with Buprenorphine and Naloxone · June 2023
Articles
Cureus
×
Patients’ Goals When Initiating Long-Acting Injectable Buprenorphine Treatment for Opioid Use Disorder: Findings from a Longitudinal Qualitative Study · June 2023
Articles
Substance Abuse Treatment, Prevention, and Policy
×
Associations of Methadone and Buprenorphine-Naloxone Doses with Unregulated Opioid Use, Treatment Retention, and Adverse Events in Prescription-Type Opioid Use Disorders: Exploratory Analyses of the OPTIMA Study · June 2023
Articles
American Journal on Addictions
×
Buprenorphine Utilization and Prescribing among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access · May 2023
Articles
JAMA Network Open
×
Treating Opioid Use Disorder in Veterans with Co-Occurring Substance Use: A Qualitative Study with Buprenorphine Providers in Primary Care, Mental Health, and Pain Settings · May 2023
Articles
Addiction Science and Clinical Practice
×
Association of Patients’ Direct Addition of Buprenorphine to Urine Drug Test Specimens with Clinical Factors in Opioid Use Disorder · March 2023
Abstracts
JAMA Psychiatry
×
Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy · March 2023
Articles
Cureus
×
Detection of Methadone and Buprenorphine in Urine Samples from Inmates of German Prisons · February 2023
Articles
Frontiers in Psychiatry